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Asthma is the most common chronic disease of childhood. Children diagnosed with asthma 
are twice as likely to have a comorbid anxiety disorder as their non-asthmatic peers. The 
presence of both asthma and anxiety in the pediatric patient creates an environment of 
poor asthma control, and places them at risk for a variety of negative health events. Little is 
known about comorbid anxiety’s role in asthma health maintenance. Research has 
identified the link between these two conditions but causation is difficult to conclude. The 
aim of this thesis is to assess the current state of the science regarding pediatric asthma 
and anxiety. This integrated review of the literature will identify the factors contributing to 
the vicious cycle of pediatric anxiety and asthma. Recommendations for practice and future 
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Asthma is one of the most common chronic diseases in the world and prevalence 
continues to rise, especially in the pediatric population (Centers for Disease Control and 
Prevention [CDC], 2011). Asthma is characterized by bronchoconstriction and 
inflammation of the airway (National Heart Lung and Blood Institute [NHLBI], 2007). In 
2001, 25.7 million people or 7.3% of the population were affected by asthma. Today, 8.4% 
of the population is affected with asthma and that number is rising (CDC, 2011). In the 
United States, one in every 10 children has asthma (Hennessy-Harstad, 2013).  
Asthma affects the pediatric population adversely every year and is the third leading 
cause for the hospitalization of children aged 15 and under (Hall, DeFrances, Williams, 
Golosinskiy, & Schwartzman, 2010).  In addition, asthma related absences from school 
make up 10.5 million school days missed annually in children ages 5-17 years (CDC, 2011). 
Asthma is costly, and according to the CDC, poor asthma control is associated with 
healthcare costs of $56 billion each year (2011). The National Heart Lung and Blood 
Insititute (NHLBI) defines well controlled asthma as: Symptoms no more than twice/week, 
nighttime awakenings no more than twice/monthly, no interference with normal activity, 
use of short-acting beta2 agonist inhaler for symptom control no more than twice/weekly, 
peak flow greater than 80% of personal best, and exacerbations no greater than once per 
year. Asthma control is the prevention of asthma exacerbations and asthma related 
functional deficits. Asthma control is accomplished through the utilization of prophylactic 
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medications, the avoidance of individual triggers, and the development of an asthma action 
plan in the event of an exacerbation. Collectively, asthma control is the goal of empowering 
the affected asthmatic and their family to gain control over this chronic disease (CDC, 
2013).  
Extensive research has identified possible asthma triggers in an effort to promote 
asthma control. Some commonly identified triggers include: smoke, pollen, dust, diet, 
animal dander, strong scents, and exercise (American Lung Association [ALA], 2013). The 
ALA has documented that strong emotions such as stress and anxiety should be considered 
potential triggers of asthma (2013).  
Additionally, children diagnosed with asthma are two to three times more likely to 
develop an anxiety disorder than their healthy (non-asthmatic) peers (Ross, Davis, & Hogg, 
2007). According to the NIMH, 8% of adolescents age 13-18 years have an anxiety disorder, 
with symptoms initially surfacing around the age of six. Of these 8%, only 18% have 
received mental health care. This means that there is a significant portion of the pediatric 
population struggling with an undetected anxiety disorder. 
 Anxiety is defined as a group of disorders that are characterized by excessive 
irrational fear and dread. One component of many anxiety disorders is panic attacks. Panic 
attacks are episodes of sudden terror characterized by feelings of impending doom usually 
lasting less than ten minutes. Panic disorders are typified by feelings of breathlessness 
(hyperventilation), pounding heartbeat, dizziness, and loss of control (National Institute of 
Mental Health [NIMH], 2013). Prolonged feelings of anxiousness can result in difficulty 
controlling stress and anxiety levels, resulting in a change in everyday activities (NIMH, 
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2013). One study conducted on 82 pediatric asthmatic patients found a prevalence rate of 
35% or 29 children with at least one DSM IV anxiety disorder (Vila, Nollet-Clemençon, de 
Blic, Mouren-Simeoni, & Scheinmann, 2000). The likelihood of the pediatric asthmatic 
population to have a co-morbid anxiety disorder has recently been the subject of increased 



















Undetected anxiety is a problem in the pediatric population; the probability of the 
pediatric asthma patient to have a comorbid anxiety disorder requires attention. Pediatric 
asthma morbidity and mortality rates have risen in recent years, signifying the need to 
update control and prevention measures. The presence of comorbid anxiety in the asthma 
patient has been found to be associated with greater functional impairment than those 
without comorbid anxiety (McCauley, Katon, Russo, Richardson, & Lozano, 2007). 
Therefore, it is imperative to explore the relationship between asthma and anxiety.  
From the cognitive theory perspective, “the unpredictable and longitudinal 
experience with asthma attacks may generate fearful or catastrophic beliefs which provoke 
panic attacks and anticipatory anxiety” (Lu, et al., 2012, p. 712). Therefore, it can be argued 
that living with an erratic, chronic condition in childhood may be anxiety inducing in itself. 
Additionally, anxiety disorders may follow an unpredictable course as well. The presence of 
feelings of anxiousness and worry in generalized anxiety disorder (GAD) are frequently not 
attributable to one specific trigger or topic (NIMH, 2013). The ambiguous etiology of 
anxiety disorders and panic attacks combined with the volatile nature of asthma 
exacerbations sets the stage for an incessant cycle. 
Dysregulation of the autonomic nervous system, as in anxiety, has been also found 
to be associated with an increased risk of bronchoconstriction (Lavoie, Boudreau, Plourde, 
Campbell, & Bacon, 2011). Bronchoconstriction is the primary mechanism in asthma 
leading to dyspnea and ensuing rescue medication use. The overlap of this symptom 
seemingly contributes to the ongoing exacerbation of both chronic asthma and anxiety. 
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Moreover, according to the CDC, hyperventilation can be caused by strong emotions 
(2012). Anxiety disorders often are accompanied by strong emotions and in some cases, 
panic attacks. According to the NIMH, panic attacks frequently involve a vicious cycle of 
panic inducing breathlessness followed by panic resulting from breathlessness (2013). 
With the primary symptom of asthma being breathlessness, it can be inferred that the 
addition of anxiety disorders and panic attacks to an asthmatic’s problem list further 
perpetuates an already vicious cycle.  
In order to effectively treat these patients struggling with asthma and anxiety, the 
interaction of these two conditions with each other must be examined. Little is known 
about co-morbid anxiety’s role in asthma health maintenance and outcomes. The link 
between these conditions has been identified but causation is difficult to conclude. The 
likelihood of these disorders to occur together is evident, however the underlying 











The aim of this thesis is to assess the current state of the science regarding pediatric 
anxiety and asthma by providing an integrated review of the literature. This integrated 
review of the literature will identify the factors contributing to the vicious cycle of pediatric 
anxiety and asthma. Recommendations for future practice and research will be made based 

















The researcher analyzed the current research on the relationship between pediatric 
asthma and anxiety to determine underlying factors influencing the cyclical relationship of 
these comorbid conditions. Databases used to find research studies included MEDLINE 
EBSCOHost, CINAHL, PsycInfo, Academic Search Premiere, and the Cochrane Database. 
Databases were accessed electronically through the UCF library to find original research 
studies, peer reviewed journal studies, literature reviews, and published dissertations. 
Abstracts of studies were screened to evaluate the conceptual relevance to this review. 
Following an initial search and collection of studies, an ancestry search was performed as 
well.  
The following terms were used to search the databases: pediatri* OR adolescen* 
AND anxiety, AND asthma. Using those search terms, 253 studies were found. Specific 
inclusion and exclusion criteria were identified to ensure that the studies collected would 
be applicable to this literature review. In 2003, the NHLBI implemented new asthma 
guidelines; therefore date parameters of January 2004 to present were entered. To be 
included, studies needed to be written in English or translated into English. International 
studies from countries other than the United States were included. However they were 
assessed thoroughly to account for cultural and societal variables that may not be 
applicable to this literature review. Studies were required to be focused on the pediatric 
asthmatic population (7-17 years old).  
Studies were excluded if they focused on subjects who had other comorbidities 
other than asthma and anxiety. Additionally, studies were excluded if they concentrated 
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primarily on caregiver anxiety. Anxiety and depression are conditions that are frequently 
assessed and identified as occurring together; therefore studies were not immediately 
excluded if both of these conditions were studied in the pediatric asthmatic patient. In this 
case, exclusion criteria was altered so that if specific scales were used to assess anxiety and 
depression separately, then the study could be included and only the information regarding 
anxiety would be used. Studies that did not directly address anxiety and studies that 
evaluated the development of new anxiety scales were also excluded. After the review of 
literature, the researcher decided to include a pilot study on young adult asthmatics 
because the literature regarding anxiety sensitivity as it relates to asthma control in 
pediatric patients was very limited.  
A total of 253 articles were identified initially from the electronic and hand 
searches, many with duplication among the databases and reference lists. Forty-three 
studies were excluded due to duplication. After review to ensure studies met PICO criteria, 
184 were excluded leaving 26 studies.  To narrow this number, Melnyk and Fineout-
Overholt (2005) rating system was applied for the hierarchy of evidence to evaluate 
research:  
Level 1: Evidence from a systematic review or meta-analysis or all relevant 
randomized controlled trials (RCTs) 
Level II: Evidence obtained from well-designed RCT’s 
Level III: Evidence obtained from well-designed controlled trials without 
randomization 
Level IV: Evidence from well-designed case-control or cohort studies 
Level V: Evidence from systematic reviews of descriptive and qualitative studies 
Level VI: Evidence from single descriptive or qualitative studies 
Level VII: Evidence from the opinion of authorities and/or reports of expert 
committees (Melnyk & Fineout-Overholt, 2005,12).  
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Any study deemed as VII was not included in this integrated literature 
review.  Using the tool, 26 studies were evaluated and 18 were excluded, leaving eight 
studies remaining. One study is Level II randomized control trial, four studies are well-
designed Level IV studies, two systematic reviews are Level V, and one well-designed pilot 
study is determined Level VI. These eight studies met the inclusion criteria for this 
integrative literature review and exhibited moderate to high quality for validity. The 
remaining articles are considered to be valuable regarding the background and significance 
















The literature search revealed three reoccurring themes present in the research. 
The interplay of biological factors, psychological factors, and unrecognized anxiety are the 
three major mechanisms behind the cyclical nature of pediatric asthma and anxiety.  
Biological Factors 
 Two studies addressed the underlying biological processes influencing the 
relationship of asthma and anxiety. Both of these studies were literature reviews featuring 
sections that offered biological theories to explain the incidence of pediatric asthma and 
anxiety to occur together.  
Autonomic Nervous System  
 Peters and Fritz propose that the most likely biological mechanism that links the 
emotional processes of anxiety and exacerbations of asthma is mediation of the autonomic 
nervous system (ANS). The ANS is directly responsible for bronchoconstriction and the 
regulation of emotion. Anxiety is characterized by stress and emotional responses, while 
the chief problem in asthma is bronchoconstriction. It is conceivable that the dysregulation 
of the ANS due to anxiety could result in bronchoconstriction and an ensuing asthma 
exacerbation (Lavoie, Boudreau, Plourde, Campbell, & Bacon, 2011). One study was 
conducted on asthmatic pediatric patients in a laboratory in which their response to 
emotionally evocative movie scenes was monitored. This study found notable autonomic 
responses associated with an increase in airway reactivity and decrease in pulmonary 
function (Peters & Fritz, 2011). Another study was conducted to measure the asthmatic 
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patient’s response to stress inducing events such as public speaking. Their pulmonary 
function was recorded before and after exposure to the stressful stimuli. The results 
showed that in 22% of the participants, significant bronchoconstriction resulted from the 
induction of stress (Peters & Fritz, 2011). Another consideration is the use of beta 2 
agonists (such as albuterol) for the treatment of bronchoconstriction. While these 
medicines are useful for bronchodilation, they may exacerbate symptoms of anxiety 
through their arousal of the ANS (Katon, Richardson, Lozano, & McCauley, 2004).  
Airway Resistance 
 In asthma, an increase in airway resistance is the result of bronchoconstriction and 
excess mucous production. The subsequent effort to overcome this increased resistance 
during respiration is the mechanism behind dyspnea in the asthmatic patient. Furthermore, 
experimental stress has been found to increase airway resistance in both pediatric 
asthmatics and their non-asthmatic peers. Asthmatic pediatric patients have a higher level 
of inherent airway resistance, so the induction of stress resulting from anxiety lends itself 
to a higher level of overall respiratory compromise (Katon et al, 2004). The experience of 
dyspnea may lead to feelings of anxiousness. However, anxiety may also cause the 
production of stress, ultimately triggering airway resistance and ensuing dyspnea. It seems 
that anxiety, airway resistance, and dyspnea each perpetuate the other. Since pediatric 
patients with asthma begin with higher inherent airway resistance, they are more likely to 




 Six studies addressed the underlying psychological processes influencing the 
relationship of asthma and anxiety. Two literature reviews and 4 quantitative, descriptive 
studies contained psychological considerations for the pediatric patient with asthma and 
anxiety.  
Symptom Perception  
 
Symptom perception refers to the way in which an individual patient reports the 
experience of their disease specific symptoms. Chen and colleagues conducted a study on 
pediatric asthmatic patients to measure their anxiety levels and symptom perception 
during a metacholine challenge. Prior to the administration of metacholine, symptom 
perception, anxiety levels, and pulmonary function were recorded This study found that 
prior to metacholine administration, increased levels of anxiety were associated with 
increased symptom perception after controlling for pulmonary function (r= .26, p< .05; 
Chen, Herman, Rodgers, Welker, & Strunk, 2006). From these results, it can be inferred that 
the higher the baseline anxiety levels of the patient are, the higher their symptom 
perception will also be. This suggests that the presence of anxiety in the pediatric asthma 
patient may lead to the perception of worsened or more abundant asthma related 
symptoms.  
Three studies stated that over-perception of asthma symptoms puts the pediatric 
patient at risk for overmedication (Chen et al, 2006; Peters & Fritz, 2011; Lavoie et al, 
2011). One study found a significant association between asthmatic adults with generalized 
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anxiety disorder (GAD) and bronchodilator rescue medication use in one week. This study 
concluded that those with GAD were likely to use their rescue bronchodilator medication at 
least ten times more often than those without GAD (Lavoie et al, 2010). The side effects of 
many bronchodilator medications are agitation and anxiety. Furthermore, inhaled steroids 
are a medication routinely used for the containment of asthma, and can contribute to 
heightened anxiety symptoms as well (Peters & Fritz, 2011). The phenomenon of 
overmedication due to the over-perception of symptoms has great potential to be a cyclical 
sub relationship in the pediatric patient with asthma and anxiety.  
Anxiety Sensitivity  
Anxiety sensitivity is defined as the “fear of arousal-related physical and 
psychological sensations” (McLeish, Zvolensky, & Luberto, 2010, p. 440). Anxiety sensitivity 
tells of a cognitive predisposition to experience increased risk of anxiety symptoms and 
panic attacks. Increased anxiety sensitivity presents as heightened awareness and fear of 
one’s response to the arousal that anxiety produces. The role of anxiety sensitivity in 
asthma is an up and coming area of research. Two of the studies reviewed in the literature 
search focused on the use of the childhood anxiety sensitivity index (ASI) to study the 
relationship of asthma and anxiety. The ASI is an 18-item self-report tool that measures the 
degree to which patients experience fear of anxiety symptoms and the negative 
consequences stemming from catastrophic thoughts. The ASI measures anxiety across 
three domains: physical concerns (fears of increased respirations/heart rate), cognitive 
concerns (fears of being mentally ill or “spacey”) and social concerns (fears of appearing 
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nervous). High anxiety sensitivity scores in asthma patients have been correlated with 
comorbid anxiety disorders (McCauley et al, 2007). Studying anxiety sensitivity is another 
outlet to understanding the interaction of anxiety in the pediatric asthmatic.  
The Child Health Survey-Asthma (CHS-A) is used to assess the physical, emotional, 
and activity limitations associated with living with asthma. One study found that scores on 
the ASI and CHS-A emotional health scores are negatively correlated (r = -.455, p< .01; 
McCauley et al, 2007). This means that as the pediatric patient becomes more fearful of 
their anxiety symptoms, their asthma specific emotional health declines giving way to 
feelings of isolation, anger, and upset. This may translate into higher baseline anxiety levels 
due to the inability to effectively cope with their asthma.  
One pilot study by McLeish, Zvolensky, and Luberto aimed to investigate this 
relationship further. They conducted a study on young adult asthmatics with the goal of 
examining the role of anxiety sensitivity on asthma control. The asthma control test (ACT) 
was used to measure the participant’s asthma control. The researchers found that the 
physical concerns of the ASI were negatively correlated with asthma control (r =-.35, 
p<.01) (McLeish et al, 2010). These findings indicate that the more anxiety surrounding 
somatic concerns a patient possesses, the more likely they are to have poorly controlled 
asthma. This relationship is not yet well understood, but is likely due to the overlap of 
physical symptoms in asthma and anxiety. Asthma shares elements of the physical arousal 
that anxiety produces (increased heart rate and respiratory rate) and fearing these physical 
responses is likely to further potentiate negative physical responses.  
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Cognitive Experience of Asthma and Comorbid Anxiety 
 Asthma and anxiety are lifelong conditions that have no cure. With proper 
treatment, both can be controlled and almost entirely contained however. The containment 
of these disorders requires great attention to possible triggers and environmental variables 
that may be influencing them. Three studies stated that the longitudinal and unpredictable 
nature of asthma is likely to induce a state of higher baseline anxiety related to the inability 
of the patient to predict exacerbations (Katon, et al, 2004; Peters & Fritz, 2011; Lavoie et al, 
2010). Peters and Fritz discussed that asthma exacerbations frequently require medical 
intervention and hospitalization. These hospitalizations are likely to provoke additional 
anxiety in the pediatric patient, during an already anxiety inducing experience. If this 
sequence of events is repeated over time, it is likely that an anxiety disorder may develop. 
At the same time, dyspnea is a principal symptom of panic attacks and can progress into 
hyperventilation. Hyperventilation may act as an irritant to asthmatic airways and further 
promote bronchoconstriction (Peters & Fritz, 2011). 
Anxiety is characterized by chronic worry and fear, sometimes resulting in panic 
attacks. If these panic attacks occur frequently, the patient may be diagnosed with panic 
disorder. The course of panic disorder is similar to that of asthma in regards to its 
unpredictable nature and importance of monitoring for triggers (Katon et al, 2004). The 
environment of a pediatric patient with both asthma and panic disorder is likely one of 




 Six of the studies addressed unrecognized anxiety as one of the chief influencing 
factors in the relationship between asthma and anxiety (Peters & Fritz, 2011; Katon et al, 
2004; Katon et al, 2006; McCauley et al, 2007; Burkhart & Rayens, 2005; Lavoie et al, 2011). 
Katon and colleagues found that 9% of 781 asthmatic youth (or 73) screened positive for 
having a comorbid anxiety disorder. Of these 73 youths, only 11 had been diagnosed with 
an anxiety disorder, according to their medical chart. This is a recognition rate of 7.2% 
(Katon et al, 2006). Unrecognized anxiety is detrimental to the pediatric asthmatic 
primarily because it complicates the effort to attain asthma control. The significant airway 
changes occurring unpredictably in conjunction with these disorders may undermine the 
youth’s self-confidence in learning to master the management of their asthma. Moreover, 
these patients may have an impaired ability to sleep, trouble concentrating, and difficulty 
making decisions due to their high baseline anxiety levels. This further suggests that they 
may be unable to make appropriate self-management decisions, further disrupting the 
control of their asthma (Lavoie, et al, 2011). Lack of confidence, repeated frightening 
episodes of breathlessness, and ineffective self-management may lead the pediatric patient 
to feel that they are not controlling their asthma well, ultimately affecting their likelihood 
to adhere to their asthma management plan (McCauley et al, 2007).  
 Burkhart and Rayens conducted a study in order to further understand the 
relationship of unrecognized anxiety on asthma management plan adherence. They studied 
the pediatric asthmatic’s health locus of control and self-concept as they relate to asthma 
adherence. Health locus of control is defined as the “perception that a health outcome will 
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be largely determined by the individual’s own actions (internal health locus of control) or 
by outside forces (external health locus of control) beyond the individual’s control” 
(Burkhart & Rayens, 2005). They found that the higher the pediatric patient’s internal locus 
of control and self-concept are, the more adherent to their asthma management plan they 
are. Additionally, they found that patients with low anxiety levels were more likely to be 
adherent (Burkhart & Rayens, 2005). It is unlikely that patients that are experiencing 
difficulties with managing their asthma and anxiety have a high internal health locus of 
control, as they are likely struggling with controlling both chronic conditions. 
Lavoie and colleagues conducted a study on 794 asthmatic adults to explore the 
association of GAD with asthma control, quality of life, and asthma specific self-efficacy. 
Asthma specific self-efficacy is very similar to an internal health locus of control, as it is 
defined as the amount of confidence that an individual has in “their ability to control or 
manage their asthma symptoms in different environments or under different conditions” 
(Lavoie et al, 2011). Both an internal locus of control and high asthma specific self-efficacy 
result from repeated cognitive experiences with managing asthma exacerbations 
successfully and without complication. Lavoie and colleagues found that the presence of 
GAD was associated with low asthma specific self-efficacy. The significant association of 
low self-efficacy and GAD suggests that the presence of an anxiety disorder complicates the 
patient’s ability to attain asthma control and furthermore decreases their confidence that 
their self-care actions are proving to be effective. They also found that after adjusting the 
results for self-efficacy, the association between asthma morbidity and GAD was no longer 
significant. These results suggest that patients with low asthma specific self-efficacy may be 
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delaying or simply not engaging in behaviors to control their asthma resulting in worse 
asthma morbidity. The rationale behind this choice to be non-adherent is likely due to the 
patient’s uncertainty that management actions such as taking medications, monitoring 
peak flow, and removing allergens from the home are actually effective at controlling 
asthma symptoms (Lavoie et al, 2011).  
The complex interaction of asthma and anxiety makes it more difficult to predict 
and manage exacerbations of each condition. Unrecognized anxiety is dangerous when 
introduced to this cycle because it lowers the patient’s perception of their ability to control 
their disease status (low asthma specific self-efficacy and/or a low internal locus of 
control). The patient may attribute their inability to control their asthma to themselves as 
being ineffective managers, instead of recognizing that they have an underlying, 
complicating comorbidity. The ensuing decrease in adherence is of great concern to the 
pediatric asthmatic patient as adherence to the management plan is imperative for the 









 The biological and psychological factors of asthma and anxiety, in conjunction with a 
poor anxiety recognition rate are interwoven to create a tangled web of health variables. 
Each component of the interaction between these comorbidities is influencing, and possibly 
exacerbating the other. For example, biological factors point to increased ANS arousal in 
the pediatric patient with asthma and anxiety, along with increased bronchoconstriction 
and more airway resistance. This change in airway may in turn elicit additional anxiety. 
Psychological factors posit that over time, these repeated cognitive experiences with 
airway changes might lead to a higher baseline of general anxiety. Over-perception of 
symptoms is a psychological factor that often accompanies higher baseline anxiety. This 
over-perception may lead to overmedication, increasing ANS arousal and further 
perpetuating the anxiety levels of the pediatric patient. The exacerbation of biological 
factors by psychological factors and vice versa goes entirely untreated when the patient has 
not yet been screened for and diagnosed with anxiety. A poor perception of a patient’s 
ability to control their asthma leads to low asthma specific self-efficacy and a low internal 
locus of control, leading to potentially decreased adherence, and worsened asthma control. 
This vicious cycle of high anxiety and poor asthma control is likely to be attributed to solely 
the patient’s asthma, when there is actually an underlying or acquired mental health 
comorbidity complicating the disease process.  
 A host of negative outcomes have been associated with the presence of asthma and 
undetected anxiety in the pediatric asthmatic. In addition to the increased difficulty in 
obtaining asthma control, pediatric patients with both asthma and anxiety have more social 
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anxiety than their non-asthmatic peers. In one study of adolescents, those who were 
experiencing asthma symptoms were more likely to report social anxiety, possibly due to 
the exhibition of symptoms and/or taking medication in the presence of peers (Bruzzese, 
Fisher, Lemp, & Warner, 2009). Increased functional impairment has also been associated 
with the presence of asthma and anxiety. One study found that youth who reported more 
symptoms of anxiety also reported greater asthma-related functional impairment 
(McCauley et al, 2007).  
 The management of chronic pediatric disease is an ever-evolving task. As the 
pediatric patient ages, the disease may alter course, requiring adjustments in medications 
and management behaviors. According to psychologist Erik Erikson, each stage of life is 
associated with a different psychosocial task. In childhood, the successful completion of 
these tasks is aimed at attaining independence, initiative, competence, and a defined 
identity (Graves & Larkin, 2006). The disruption of these stages may result in unresolved 
psychosocial conflicts and prevent the patient from successfully progressing to the next 
stage. Chronic conditions such as asthma and anxiety may interrupt the psychosocial 
development of the patient, especially when these conditions are not well controlled or are 
not being treated properly (Knafl & Deatrick, 2003). For this reason, it is crucial to consider 
the impact of asthma and unrecognized anxiety on the pediatric patient’ s physical health, 
mental health, and development. Figure 1 represents a conceptual model to describe the 


















Figure 1:  Adverse impact of unrecognized anxiety on pediatric asthma 




One cannot assess the pediatric patient without also considering the family. 
According to McQuaid and colleagues, the integration or lack of integration of the asthma 
management plan into the family’s system has implications for asthma outcomes (2005). 
Because of this, the Family Management Style Framework (FMSF) may provide insight as to 
how a family deals with chronic childhood conditions such as asthma and anxiety (Knafl, 
Deatrick, & Gallo, 2008). The FMSF contains three components that are reliant upon one 
another and vary for each one of the family members. These components are: definition of 
situation (the way in which each individual family member defines fundamental aspects of 
the chronic condition), management behaviors (the behaviors each family member exhibits 
in an effort to manage the condition), and perceived consequences (each family member’s 
perceptions of how the condition is impacting the family) (Hines, 2011). The interaction of 
these three components provides a foundation to describe the Family Management Style 
(FMS), or the pattern of the family’s responses to each of these components. The overall 
goal of utilizing the FMSF to define FMS is to identify the family’s strengths and weaknesses 
in regards to managing the pediatric patient’s chronic condition in an effort to optimize 
both individual and family functioning (Knafl et al, 2008).  
 The management of a pediatric chronic condition is a complex task for the family. 
There are many developmental, psychological, and biological factors to consider. The 
importance of understanding and utilizing the FMSF is essential in the both the correct 
identification of the familial management factors at play and the holistic development of 
the treatment plan (Hines, 2011). Both asthma and anxiety are chronic conditions that have 
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overlapping symptoms and the potential to exacerbate each other. It is imperative to 
include the FMSF in future studies because pediatric chronic conditions impact the entire 
family. In order to further explore the relationship between anxiety and asthma, it is 
important to also explore the influence of the family on the chronic conditions and the 
impact of the chronic conditions on the family.  
Recommendations for Practice 
 
As previously stated, only 7.2% of pediatric asthmatic patients who screened 
positive for an anxiety disorder had been diagnosed according to their medical chart. This 
is a very low recognition rate. With as many as one in six (16.7%) pediatric asthmatics 
meeting criteria for a comorbid mental health disorder, it is of utmost importance to 
increase recognition rates (Katon et al, 2006). One recommendation is to begin screening 
pediatric asthmatics for comorbid anxiety. Screening should take place in the outpatient 
setting, as it is likely the ideal location for the most accurate screening results. Patients in 
the emergency department and inpatient hospital settings may exhibit false positive results 
because these settings are likely to induce a higher state of anxiety. One method to avoid 
false positive results in such settings is to use a screening tool that measures trait anxiety 
and the presence of anxiety disorders according to the months prior to hospitalization.  
The Screen for Child Anxiety Related Emotional Disorders (SCARED) is a 41-item 
tool used to screen for anxiety disorders in the pediatric population. It includes statements 
like “I worry about other people liking me,” and asks the participant to rate on a scale of 0 
(not true or hardly ever true) to 2 (very true or often true) how the given statement 
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applied to them in the previous three months. The SCARED is available in a child version 
(SCARED-C) and a caregiver version (SCARED-P). The SCARED has been found to 
demonstrate good convergent and divergent validity (Monga et al., 2000). The SCARED has 
also been found to be reliable and valid in cross-cultural samples (Hale, Crocetti, 
Raaijmakers, & Meeus, 2011). Six of the articles used for this integrated literature review 
addressed the importance of screening this population for comorbid anxiety, with three 
urging the importance of screening. Peters and Fritz recommend screening in the primary 
care setting with a clinical interview. They also recommend referring those at high risk to a 
psychiatrist for a full diagnostic interview (Peters & Fritz, 2011).  
Early detection of the presence of an anxiety disorder and the role it has on asthma 
management can prevent overmedication, unnecessary escalation of treatment, and may 
improve asthma control (Marriage & Henderson, 2012). Additionally, anxiety screening 
and early detection can decrease healthcare utilization and consequently lower healthcare 
costs (Tibosch, Verhaak, & Merkus, 2011). Perhaps the most important reason to detect 
anxiety early in this population is to minimize the impact it has on the overall well being of 
the children and their families, allowing them to more effectively manage the chronic 
diseases together.  
Recommendations for Research  
 Future research is needed regarding the biological processes behind asthma and 
anxiety’s shared patterns of ANS arousal and airway resistance. A comparison between 
groups of asthmatics with and without a diagnosed anxiety disorder during exposure to 
anxiety arousing stimuli is warranted. Additionally, current anxiety treatment protocols 
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need to be evaluated for their effectiveness in treating anxiety as it relates to asthma 
control.  
The findings of this literature review did not reveal any previous research of the 
family dynamic in regards to the management of pediatric asthma and anxiety. It is crucial 
to explore the family dynamic because the effective management of pediatric chronic 
conditions is dependent upon it (McQuaid, Walders, Kopel, Fritz, & Klinnert, 2005). The 
interaction of chronic asthma and anxiety is complex and the family’s perceptions and 
behaviors likely play a key role in the management of these conditions. Because of this it is 
essential to examine the family management style (FMS) in the effort to maximize asthma 
control, anxiety containment, and harmony in the household environment.  
Limitations 
 One of the limitations of this literature review is the search parameter of January 
2004 to present. This parameter potentially excludes applicable studies conducted prior to 
this date. The selection of this parameter is due to the implementation of new asthma 
guidelines in 2003. An ancestry search of pertinent articles was conducted in order to 
minimize the impact of this date parameter on comprehensive data collection. Another 
limitation of this literature review is the inclusion of two studies conducted on the adult 
population. These well-designed Level IV and Level VI studies may not be applicable to the 
pediatric population, but were included in this review as they provided additional 




The presence of comorbid anxiety in the pediatric asthmatic patient sets the stage 
for a variety of ensuing adverse asthma outcomes. The interplay of psychological factors 
and biological factors negatively influence the experience of asthma in the child and 
complicate their management efforts. Anxiety must first be detected in this population to 
minimize the impact on the child’s self-confidence, development, and overall health. The 
principal recommendation for practice is to screen for comorbid anxiety in the pediatric 
asthmatic population in the primary care setting. Future research should be focused on 
examining the ANS response in pediatric asthmatics with and without anxiety. Additionally, 
future research should begin to evaluate the current treatment protocols in place for the 
management of anxiety disorders in regards to their effectiveness in the patient with 
comorbid asthma. Finally, future research aimed at exploring the family dynamic in the 
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